Switch to:

10x Genomics EV-to-EBITDA

: -244.46 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, 10x Genomics's enterprise value is $8,538.7 Mil. 10x Genomics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was $-34.9 Mil. Therefore, 10x Genomics's EV-to-EBITDA for today is -244.46.

NAS:TXG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -445.5   Med: -207.1   Max: -11.4
Current: -244.46

-445.5
-11.4

During the past 3 years, the highest EV-to-EBITDA of 10x Genomics was -11.40. The lowest was -445.50. And the median was -207.10.

NAS:TXG's EV-to-EBITDA is ranked lower than
99.99% of the 374 Companies
in the Healthcare Providers & Services industry.

( Industry Median: 13.10 vs. NAS:TXG: -244.46 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-07-03), 10x Genomics's stock price is $89.99. 10x Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was $-0.74. Therefore, 10x Genomics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


10x Genomics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

10x Genomics Annual Data
Dec17 Dec18 Dec19
EV-to-EBITDA 0.00 0.00 -123.81

10x Genomics Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -11.71 -123.81 -163.81

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


10x Genomics EV-to-EBITDA Distribution

* The bar in red indicates where 10x Genomics's EV-to-EBITDA falls into.



10x Genomics EV-to-EBITDA Calculation

10x Genomics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8538.701/-34.929
=-244.46

10x Genomics's current Enterprise Value is $8,538.7 Mil.
10x Genomics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was -8.971 (Jun. 2019 ) + -6.846 (Sep. 2019 ) + -3.189 (Dec. 2019 ) + -15.923 (Mar. 2020 ) = $-34.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


10x Genomics  (NAS:TXG) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

10x Genomics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=89.99/-0.737157
=

10x Genomics's share price for today is $89.99.
10x Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was -0.117157 (Jun. 2019 ) + -0.33 (Sep. 2019 ) + -0.07 (Dec. 2019 ) + -0.22 (Mar. 2020 ) = $-0.74.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


10x Genomics EV-to-EBITDA Related Terms


10x Genomics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)